Loading chat...
TX SB241
Bill
Status
Passed
5/27/2023
Primary Sponsor
Charles Perry
Click for details
AI Summary
Legislative Description
Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability.
Health
Last Action
Effective on . . . . . . . . . . . . . . . September 1, 2024
5/27/2023
Committee Referrals
Public Health4/10/2023
Health & Human Services2/15/2023
Full Bill Text
No bill text available